Загрузка...
Peginesatide for the treatment of anemia due to chronic kidney disease – an unfulfilled promise
INTRODUCTION: The introduction of recombinant human erythropoietin revolutionized the management of anemia in patients with chronic kidney disease (CKD). In order to circumvent costly recombinant DNA technology, synthetic chemistry techniques were used to manufacture peginesatide, a synthetic peptid...
Сохранить в:
| Опубликовано в: : | Expert Opin Drug Saf |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5286458/ https://ncbi.nlm.nih.gov/pubmed/27551882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14740338.2016.1218467 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|